Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 240,613 m |
| EPS, EUR | 2.75 |
| P/B ratio | 6.1 |
| P/E ratio | 29.6 |
| Dividend yield | 1.71% |
| Revenue, EUR | 50,010 m |
| Net income, EUR | 6,506 m |
| Profit margin | 13.01% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 3.77% | Equity United States Health Care Biotech | 45 |
| Leverage Shares 5x Long Nasdaq 100 ETP | 0.38% | Equity United States Technology | 23 |
| Leverage Shares -5x Short Nasdaq 100 ETP | 0.38% | Equity United States Technology | 7 |
| YTD | -1.58% |
| 1 month | -0.64% |
| 3 months | +8.36% |
| 6 months | +31.78% |
| 1 year | +19.16% |
| 3 years | +22.25% |
| 5 years | - |
| Since inception (MAX) | +85.12% |
| 2025 | +24.41% |
| 2024 | +3.67% |
| 2023 | -3.39% |
| 2022 | +23.35% |
| Volatility 1 year | 26.05% |
| Volatility 3 years | 22.85% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.74 |
| Return per risk 3 years | 0.30 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -20.82% |
| Maximum drawdown 3 years | -26.81% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -26.81% |